The boosting effect of STING-L and cognate CART cells was more pronounced on endogenous tumor-specific T cells, as indicated by the increased number of tumor-infiltrating Tetr+ cells and their enhanced expression of CXCR3, CD25, and GzB in the combination group. Here, STING1 is linked to neoplasm.